Previous 10 | Next 10 |
Today, we take an in-depth look at clinical-stage immuno-oncology company named Marker Therapeutics. The company has multiple 'shots on goal', heavy insider buying and recently addressed its funding needs. A full investment analysis follows in the paragraphs below. For furth...
Popular Penny Stocks On Social Media Gaining Ground Right Now Penny stocks and social media have gone hand-in-hand this year. With the rise in popularity of things like Reddit, Twitter, & even Facebook becoming hubs for investing conversation, retail traders have become more in tune...
Sypris Solutions SYPR +34% on winning contract for deep space program.Silicon Laboratories SLAB +16% as Skyworks buys Infrastructure & Automotive business of the Company.LM Funding America LMFA +14% on plans to purchase up to $2.0M in digital assets.Sigma Lab...
MRKR's MultiTAA tech is proven at Baylor to be efficacious and safe in lymphoma and other trials. However, stock is depressed due to partial hold, lack of self-sponsored trial, etc. Looks like an early stage opportunity. For further details see: Marker Therapeutics: Unde...
Marker Therapeutics (NASDAQ: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, announced that it has closed on an underwritten public off...
If you know what penny stocks are, you understand how risk plays a role. But you can’t expect uncapped gain potential from safe investments. The beauty of buying penny stocks, is having the ability to leverage less capital in exchange for a much larger gain percentage. Defined as...
Updated interim data provided by AstraZeneca (AZN) yesterday from its late-stage COVID-19 vaccine trial in the U.S., should address the data integrity issue, UBS wrote in a note. AstraZeneca ADRs are trading marginally up in before hours.The Analysts led by Michael Leuchten with a buy ra...
Gainers: [[PLBY]] +14.5%. [[SLDB]] +9.8%. [[TIGR]] +7.8%. [[IPHI]] +6.4%. [[CLSD]] +5.7%.Losers: [[AAME]] -7.2%. [[HMHC]] -4.9%. [[MRKR]] -4.7%. [[ISEE]] -4.6%. [[NMIH]] -12.5%. For further details see: SLDB, PLBY, AAME and HMHC among after-hours movers
Gainers: Support.com (SPRT) +246%.Jiayin Group (JFIN) +40%.Summer Infant (SUMR) +36%.Hall of Fame Resort & Entertainment (HOFV) +32%.Recon Technology (RCON) +31%.Seneca Biopharma (SNCA) +24%.Dyadic International (DYAI) +22%.DarioHealth (DRIO) +20%.Marker Therapeutics (MRKR) ...
Gainers: Seneca Biopharma (SNCA) +25%, DarioHealth (DRIO) +25%, Dyadic International DYAI +24%, Marker Therapeutics (MRKR) +19%, Immunocore Holdings (IMCR) +11%.Losers: Odonate Therapeutics ODT -76%, Foghorn Therapeutics (FHTX) -13%,...
News, Short Squeeze, Breakout and More Instantly...
Marker Therapeutics Inc. Company Name:
MRKR Stock Symbol:
NASDAQ Market:
Marker Therapeutics Inc. Website:
Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study Study participant with Non-Hodgkin’s Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell therapy remains in complete response...
Preliminary data from study in patients with lymphoma enrolled at City of Hope National Medical Center was presented at the 11 th Global Summit on Hematologic Malignancies in Whistler, BC, Canada Study participants tolerated initial dose level well and demonstrated durab...